y 27632 has been researched along with Liver Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, R; Han, J; Hu, Z; Ma, X; Zhao, D | 1 |
| Fujimura, A; Kawaguchi, A; Ohmori, M | 1 |
| Jeppsson, B; Laschke, MW; Menger, MD; Slotta, JE; Thorlacius, H; Thorlacius, K; Wang, Y | 1 |
3 other study(ies) available for y 27632 and Liver Diseases
| Article | Year |
|---|---|
Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function.
Topics: Alanine Transaminase; Amides; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Cyclooxygenase 2; DNA-Binding Proteins; Endotoxemia; Female; Hepatocytes; High Mobility Group Proteins; Lipopolysaccharides; Liver; Liver Diseases; Male; Malondialdehyde; Mice, Inbred C57BL; Mitochondria; Organophosphorus Compounds; Peroxidase; Piperidines; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; Superoxide Dismutase | 2016 |
Partial protective effect of Y-27632, a Rho kinase inhibitor, against hepatic ischemia-reperfusion injury in rats.
Topics: Alanine Transaminase; Amides; Animals; Aspartate Aminotransferases; Blood Pressure; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Injections, Intravenous; Intracellular Signaling Peptides and Proteins; Liver; Liver Diseases; Male; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Reperfusion Injury; rho-Associated Kinases; Time Factors | 2004 |
Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Animals; Apoptosis; Cell Communication; Chemokines, CXC; Chemotaxis, Leukocyte; Disease Models, Animal; Endothelial Cells; Endotoxemia; Hepatic Artery; Hepatocytes; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Regional Blood Flow; rho-Associated Kinases; Tumor Necrosis Factor-alpha | 2006 |